These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8273683)

  • 1. Radiologic appearance of implantable cardiac defibrillators.
    Eagar G; Gutierrez FR; Gamache MC
    AJR Am J Roentgenol; 1994 Jan; 162(1):25-9. PubMed ID: 8273683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonthoracotomy lead implantable cardioverter defibrillators: normal radiographic appearance.
    Daly BD; Hummel JD; Langberg J; Strickberger SA; Kalbfleisch S; Morady F; Cascade PN
    AJR Am J Roentgenol; 1993 Oct; 161(4):749-52. PubMed ID: 8372750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pacemakers and implantable cardioverter defibrillators, unknown to chest radiography: review, complications and systematic reading.
    Alandete Germán SP; Isarria Vidal S; Domingo Montañana ML; De la Vía Oraá E; Vilar Samper J
    Eur J Radiol; 2015 Mar; 84(3):499-508. PubMed ID: 25563861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malfunction of implantable cardioverter defibrillators placed by a nonthoracotomy approach: frequency of malfunction and value of chest radiography in determining cause.
    Drucker EA; Brooks R; Garan H; Sweeney MO; Ruskin JM; McGovern BA; Miller SW
    AJR Am J Roentgenol; 1995 Aug; 165(2):275-9. PubMed ID: 7618539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiography of cardiac conduction devices: a comprehensive review.
    Aguilera AL; Volokhina YV; Fisher KL
    Radiographics; 2011 Oct; 31(6):1669-82. PubMed ID: 21997988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioverter-defibrillator systems implanted without thoracotomy: radiographic findings.
    Chmielewski SR; Zegel HG; Gottlieb C; Freiman DB
    AJR Am J Roentgenol; 1993 Nov; 161(5):943-6. PubMed ID: 8273630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erosion of an extrapericardial implantable cardioverter defibrillator patch through the gastric fundus with fistulous tract formation.
    Nathan S; Piccione W; Kumar A; Attanasio S; Schaer GL
    Cardiol Rev; 2006; 14(6):e21-3. PubMed ID: 17053368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Care of patients with implanted cardioverters-defibrillators: what every physician should know].
    Krivan L; Sepsi M; Semrád B
    Vnitr Lek; 2004 Jan; 50(1):54-60. PubMed ID: 15015230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chest radiography in the ICU: Part 2, Evaluation of cardiovascular lines and other devices.
    Godoy MC; Leitman BS; de Groot PM; Vlahos I; Naidich DP
    AJR Am J Roentgenol; 2012 Mar; 198(3):572-81. PubMed ID: 22357995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on implantable cardioverter defibrillators: knowing the differences in devices and their impact on patient care.
    Nichols K; Collins J
    AACN Clin Issues; 1995 Feb; 6(1):31-43. PubMed ID: 7736302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Tubes and lines" in thoracic radiography: malpositioning and complications].
    Wunderbaldinger P
    Wien Med Wochenschr; 2001; 151(21-23):524-31. PubMed ID: 11762247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pacemakers and implantable cardiac defibrillators in dermatologic surgery.
    Matzke TJ; Christenson LJ; Christenson SD; Atanashova N; Otley CC
    Dermatol Surg; 2006 Sep; 32(9):1155-62; discussion 1162. PubMed ID: 16970697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of ventricular tachyarrhythmia with implantable cardioverters/defibrillators--mortality and complications using epicardial electrodes].
    Wietholt D; Block M; Isbruch F; Böcker D; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Z Kardiol; 1993 Mar; 82(3):150-61. PubMed ID: 8475651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reuse of explanted, resterilized implantable cardioverter-defibrillators: a cohort study.
    Pavri BB; Lokhandwala Y; Kulkarni GV; Shah M; Kantharia BK; Mascarenhas DA
    Ann Intern Med; 2012 Oct; 157(8):542-8. PubMed ID: 23070487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection.
    Pickett RA; Saavedra P; Ali MF; Darbar D; Rottman JN
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1095-9. PubMed ID: 15363086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implantable defibrillators in the management of malignant ventricular tachyarrhythmias. Experience at the Arrhythmia National Center].
    Asenjo R; Oyarzún R; González M; Morales P; Zamorano J; Brunet L; Morris R; Ortiz M
    Rev Med Chil; 1998 Jul; 126(7):803-13. PubMed ID: 9830773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.